Can scleromyxedema be differentiated from nephrogenic fibrosing dermatopathy by the distribution of the infiltrate?
Satter
Elizabeth K
EK
Metcalf
John S
JS
Maize
John C
JC
D003937:Diagnosis, Differential; D005260:Female; D005355:Fibrosis / Q000150:complications; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D053718:Scleromyxedema / Q000175:diagnosis / Q000473:pathology*; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000175:diagnosis / Q000209:etiology / Q000473:pathology*